文献速递神经介入DSA

老年急性卒中血管内治疗的系统综述与Meta分析

Endovascular Management of Acute Stroke in the Elderly: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJNR Am J Neuroradiol · 2018-03-22

该系统综述与Meta分析纳入17项研究共860例80岁以上急性缺血性卒中患者,评估血管内治疗的安全性与疗效。3个月良好功能结局率为27%(95%CI 21%-32%),死亡率为34%(95%CI 23%-44%),成功再通率为78%(95%CI 72%-85%),症状性颅内出血发生率为8%(95%CI 5%-10%)。作者认为年龄不应作为是否提供血管内治疗的判别因素。

要点

  • 80岁以上急性卒中患者血管内治疗后3个月良好功能结局(mRS≤2)率为27%。
  • 成功再通率78%,症状性颅内出血发生率8%,3个月死亡率34%。
  • 作者结论认为年龄不应作为决定是否行血管内治疗的判别因素。

核心结论

  • 80岁以上急性卒中患者接受血管内治疗,尽管合并症发生率较高,仍有较高比例可获得良好功能恢复;结局劣于年轻患者,但至少1/4的80岁以上患者可在3个月时恢复独立功能;需要更多研究改善老年患者选择,但年龄不应作为是否提供血管内治疗的判别因素。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、MEDLINE和EMBASE(1992年至2017年第35周),由两名独立评价者筛选研究和提取数据,纳入17项报告860例80岁以上急性卒中患者血管内治疗的研究,采用随机效应模型进行Meta分析,主要终点为3个月良好功能结局(改良Rankin量表评分≤2)。

诊断标准与关键数值

  • 3个月良好功能结局(改良Rankin量表评分≤2)率为27%(95%CI 21%-32%);3个月死亡率为34%(95%CI 23%-44%);成功再通率为78%(95%CI 72%-85%);操作相关并发症发生率为11%(95%CI 4%-17%);颅内出血发生率为24%(95%CI 15%-32%);症状性颅内出血发生率为8%(95%CI 5%-10%);平均至腹股沟穿刺时间为251分钟(95%CI 224-278分钟);操作时间为99分钟(95%CI 67-131分钟)。

临床应用与阅片要点

  • 作者结论认为,年龄不应作为决定是否为急性卒中患者提供血管内治疗的判别因素。

局限性

  • 所有结局指标的I²值均高于50%,提示存在显著异质性。
  • 需要更多研究以改善老年患者的筛选。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Acute ischemic stroke occurs more frequently, presents with more severe symptoms, and has worse outcomes in elderly patients. The safety and efficacy of endovascular therapy for acute stroke in this age group has not been fully established.

PURPOSE: We present the results of a systematic review and meta-analysis examining clinical, procedural, and radiologic outcomes of endovascular therapy for acute stroke in patients older than 80 years of age.

DATA SOURCES: We searched PubMed, MEDLINE, and EMBASE from 1992 to week 35 of 2017 for studies evaluating endovascular therapy for acute stroke in the elderly.

STUDY SELECTION: Two independent reviewers selected studies and abstracted data. The primary end point was good functional outcome at 3 months defined as modified Rankin Scale score of ≤2.

DATA ANALYSIS: Data were analyzed using random-effects meta-analysis.

DATA SYNTHESIS: Seventeen studies reporting on 860 patients were included. The rate of good functional outcome at 3 months was 27% (95% CI, 21%-32%). Mortality at 3 months was 34% (95% CI, 23%-44%). Successful recanalization was achieved in 78% of patients (95% CI, 72%-85%). Procedure-related complications occurred in 11% (95% CI, 4%-17%). The incidence of intracranial hemorrhage was 24% (95% CI, 15%-32%), and for symptomatic intracranial hemorrhage, it was 8% (95% CI, 5%-10%). The mean time to groin was 251 minutes (95% CI, 224-278 minutes). Procedure time was 99 minutes (95% CI, 67-131 minutes).

LIMITATIONS: I2 values were above 50% for all outcomes, indicating substantial heterogeneity.

CONCLUSIONS: Good functional recovery in octogenarians treated with endovascular therapy for acute stroke can be achieved in a high proportion of patients despite the higher incidence of comorbidity in this cohort. Outcomes are inferior to those reported for younger patients; however, endovascular therapy can allow at least 1 in 4 patients older than 80 years of age to regain independent function at 3 months. More research is required to improve patient selection in the elderly, but age should not be a discriminator when deciding to offer endovascular therapy for patients with acute stroke.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Hilditch CA, Nicholson P, Murad MH, et al. Endovascular Management of Acute Stroke in the Elderly: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2018. PMID: 29567654. doi:10.3174/ajnr.A5598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。